Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.
Department of Medicine, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.
Kidney360. 2021 Apr 8;2(8):1251-1260. doi: 10.34067/KID.0007632020. eCollection 2021 Aug 26.
In the general population, genetic risk for high BP has been associated with cardiovascular disease, but not kidney function or incident CKD. These relationships have not been studied longitudinally in participants with CKD. We examined whether BP genetic risk predicts cardiovascular disease and kidney disease progression in patients with CKD.
We included 1493 African- and 1581 European-ancestry participants from the Chronic Renal Insufficiency Cohort who were followed for 12 years. We examined associations of BP genetic risk scores with development of cardiovascular disease (myocardial infarction, congestive heart failure, or stroke) and CKD progression (incident ESKD or halving of eGFR) using Cox proportional hazards models. Analyses were stratified by race and included adjustment for age, sex, study site, and ancestry principal components.
Among European-ancestry participants, each SD increase in systolic BP and pulse pressure genetic risk score conferred a 15% (95% CI, 4% to 27%) and 11% (95% CI, 1% to 23%), respectively, higher risk of cardiovascular disease, with a similar, marginally significant trend for diastolic BP. Among African-ancestry participants, each SD increase in systolic and diastolic BP genetic risk score conferred a 10% (95% CI, 1% to 20%) and 9% (95% CI, 0% to 18%), respectively, higher risk of cardiovascular disease. Higher genetic risk was not associated with CKD progression.
Genetic risk for elevation in BP was associated with increased risk of cardiovascular disease, but not CKD progression.
在普通人群中,高血压的遗传风险与心血管疾病相关,但与肾功能或慢性肾脏病(CKD)的发生无关。这些关系在 CKD 患者中尚未进行纵向研究。我们研究了高血压遗传风险是否可预测 CKD 患者的心血管疾病和肾脏疾病进展。
我们纳入了慢性肾功能不全队列中 1493 名非洲裔和 1581 名欧洲裔参与者,这些参与者随访时间为 12 年。我们使用 Cox 比例风险模型,检验了血压遗传风险评分与心血管疾病(心肌梗死、充血性心力衰竭或中风)和 CKD 进展(终末期肾病或 eGFR 减半的发生)之间的关联。分析按种族分层,并包括年龄、性别、研究地点和祖系主成分的调整。
在欧洲裔参与者中,收缩压和脉压遗传风险评分每增加 1 个标准差,患心血管疾病的风险分别增加 15%(95%CI,4%至 27%)和 11%(95%CI,1%至 23%),舒张压也呈现类似的、略有统计学意义的趋势。在非洲裔参与者中,收缩压和舒张压遗传风险评分每增加 1 个标准差,患心血管疾病的风险分别增加 10%(95%CI,1%至 20%)和 9%(95%CI,0%至 18%)。较高的遗传风险与 CKD 进展无关。
血压升高的遗传风险与心血管疾病风险增加相关,但与 CKD 进展无关。